Pediatrix Medical Group Financials - Benzinga

Pediatrix Medical Group Inc

MDNYSE

Trade with Public

Trade with Public

$26.85

0.050.19%

Ult. Agg.: Aug 28, 9:29 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

Pediatrix Medical Group Financials

Pediatrix Medical Group (MD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 18.87 percent increase over earnings of $0.53 per share from

Benzinga Newsdesk

PRO
Pediatrix Reports Q2 Payor Mix Remains Stable, No Material Changes In Net Revenue Trends; Reaffirms FY26 Adj EBITDA Outlook Of $280M-$300M

Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today provided an update on its second quarter 2026 business trends.In response to recent

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Pediatrix Reaffirms FY2026 Adjusted EBITDA Outlook Of $280M-$300M

Benzinga Newsdesk

PRO
Pediatrix Medical Group Q1 Adj. EPS $0.44 Beats $0.38 Estimate, Sales $476.196M Beat $465.830M Estimate

Benzinga Newsdesk

Earnings Scheduled For February 19, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved